Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?

Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer? ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
27 Feb 2015

When and whether to conduct endocrine therapy in non-metastatic prostate cancer

Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark
When and whether to conduct endocrine therapy in non-metastatic prostate cancer ( Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark )
27 Feb 2015

Optimizing survival in advanced prostate cancer: Welcome and introduction

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015

Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival

Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015

Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future?

Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future? ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
29 Jan 2015

Hormone receptor function in breast cancer therapy

Dr Wilbert Zwart, Netherlands Cancer Instititute (NKI), Amsterdam, The Netherlands
Hormone receptor function in breast cancer therapy ( Dr Wilbert Zwart, Netherlands Cancer Instititute (NKI), Amsterdam, The Netherlands )
6 Jan 2015

Comment: SABCS 2014 Highlights

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: SABCS 2014 Highlights ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

Comment: Reducing fat intake reduces death rates in some breast cancer patients

Prof Kent Osborne - Baylor College of Medicine, Houston, USA
Comment: Reducing fat intake reduces death rates in some breast cancer patients ( Prof Kent Osborne -  Baylor College of Medicine, Houston, USA )
16 Dec 2014

Tamoxifen lowered breast cancer rates among high-risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
16 Dec 2014

Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer

Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2014

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases

Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )
11 Dec 2014